Clinical trial Recruiting at 1 site Observational Ages 18 and up

Comparison of meta-PENG vs suprainguinal fascia iliaca block for hip fracture pain

Official title: Comparison of the Effects of Ultrasound-Guided Meta-PENG Block and Suprainguinal Fascia Iliaca Plane Block in Patients Undergoing Hip Fracture Surgery Under Spinal Anesthesia

Run by Sehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research Hospital · NCT07612761 · Data updated 2026-11-12

This study tests whether two ultrasound-guided nerve blocks help with pain control for adults having hip fracture surgery under spinal anesthesia.

More Postoperative Pain trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment80 (estimated)
SponsorSehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research Hospital
Academic / other
Locations1 site (Istanbul, Istanbul)
StatusRecruiting
StartedMay 14, 2026
Main results expectedDecember 31, 2026
Study endsDecember 31, 2026
Registry record updatedMay 29, 2026
Trial IDNCT07612761 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (18+) with hip fracture scheduled for surgery under spinal anesthesia, ASA I–III, who consent to participate.

Probably not a fit

Patients with higher ASA status (IV-V) or contraindications to regional anesthesia may not benefit from these blocks.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a prospective observational study at a single center comparing two regional anesthesia techniques: the meta-PENG block and the suprainguinal fascia iliaca plane block. Participants are adults with hip fractures undergoing surgery under spinal anesthesia, and treatment choice is based on routine clinical practice rather than randomization. The main outcome is pain during positioning for spinal anesthesia, measured on a numeric scale, with additional pain and analgesia data collected as available. The study aims to describe real-world use and differences in perioperative analgesia between the two blocks. Safety monitoring and eligibility criteria are defined, including ASA I–III status and informed consent.

Why it matters

Potential benefit: If one block provides better pain relief with fewer side effects, patients may experience less discomfort and easier recovery.

How similar studies have gone: Regional anesthesia techniques such as fascia iliaca and PENG blocks have shown analgesic benefits in hip fracture care, but direct head-to-head observational comparisons like this are fewer and primarily exploratory.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age greater than 18 years
* ASA physical status I-III
* Scheduled to undergo hip fracture surgery under spinal anesthesia
* Written informed consent obtained from the patient or the patient's legal representative

Exclusion Criteria:

* Refusal to participate in the study
* ASA physical status IV-V
* Presence of central or autonomic nervous system disease
* Known allergy to the drugs used in the study

Where it's running

  • Sancaktepe Sehit Prof. Dr. Ilhan Varank Training and Research Hospital
    Istanbul, Istanbul, Turkey (Türkiye)
    Recruiting

Study contacts

  • Principal investigator: Sule Altuncu, MD — Sehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research Hospital
  • Study coordinator: Sule Altuncu, MD
  • Email: sule.621@hotmail.com
  • Phone: +90 216 606 33 00

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.